ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
126.657,47
-0,55%
S&P 500
5.096,58
-0,38%
US Dollar vs BRL
5,1695
1,00%
Bitcoin
60.950,17
-4,52%
Brent Oil
85,52
-2,02%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Alvontech (ALVO)

  7. Alvontech (ALVO) Notícias

ALVO Alvontech

14,67
0,45 (3,16%)
Última atualização: 11:16:00
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Alvontech ALVO NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,45 3,16% 14,67 11:16:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
14,67 14,49 14,76 14,22
mais cotações »

Notícias Recentes

Data Hora Fonte Título
30/04/202405:00GLOBEU.S. Commercialization Agreement with Quallent to Drive..
24/04/202405:00GLOBEAlvotech Announces Topline Results from a Confirmatory..
19/04/202407:10GLOBEAlvotech signs U.S. agreement to expand access for newly..
16/04/202418:43BWAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
16/04/202418:30GLOBEAlvotech and Teva Announce U.S. FDA Approval of SELARSDI™..
03/04/202408:41GLOBEAlvotech Hosts Audio Call for Investors at 8:15 am EDT on..
22/03/202417:15GLOBEAlvotech Announces Increase in Number of Own Shares
20/03/202417:15GLOBEAlvotech Reports Financial Results for Full Year 2023 and..
20/03/202408:17IHMARKETNEWSU.S. Index Futures Trade Sideways Amid Anticipation of Fed’s..
05/03/202418:00GLOBEAlvotech Announces Webcast of Full Year 2023 Financial..
29/02/202418:05GLOBEAlvotech Appoints Interim Chief Quality Officer
26/02/202406:25GLOBEAlvotech Accepts Offer for the Sale of Shares for a value of..
23/02/202422:15GLOBEAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
23/02/202422:15BWAlvotech and Teva Announce U.S. Approval of SIMLANDI®..
15/02/202408:30GLOBEAlvotech Announces Expected Global Market Entry Dates for..
29/01/202406:00GLOBEAlvotech Announces Positive Top-Line Results from a..
19/01/202414:31DJNAlvotech Shares Climb After FDA Concludes Facility..
19/01/202413:30GLOBEAlvotech Provides Update on Status of Biologics License..
10/01/202405:30GLOBESTADA and Alvotech secure approval for Uzpruvo, Europe’s..
03/01/202405:30GLOBEAlvotech Clinical Study Results Demonstrate Therapeutic..
29/11/202306:00GLOBEAlvotech Announces Positive Top-Line Results from a..
28/11/202318:15GLOBEAlvotech Reports Financial Results for First Nine Months of..
21/11/202310:00GLOBEAlvotech to Report Financial Results for the First Nine..
14/11/202309:00GLOBEAlvotech and JAMP Pharma Announce Receipt of Marketing..
10/11/202311:30GLOBESTADA and Alvotech receive positive CHMP opinion for..
07/11/202310:00GLOBEAlvotech to Present at the Jefferies 2023 London Healthcare..
12/10/202305:00GLOBEAlvotech Provides Update on Status of U.S. Biologics License..
03/10/202309:29BWKashiv BioSciences Enters into Exclusive Licensing Agreement..
03/10/202306:00GLOBEAlvotech Enters into Exclusive Licensing Agreement with..
25/09/202305:00GLOBEAlvotech Announces Approval in Japan of AVT04 (ustekinumab),..
20/09/202305:30GLOBEAlvotech Provides U.S. Regulatory Update on AVT02, a..
05/09/202310:30GLOBEAlvotech Announces Changes to the Leadership Team
30/08/202317:15GLOBEAlvotech Reports Financial Results for First Six Months of..
29/08/202306:00GLOBEAlvotech and Bioventure Announce Approval of AVT02..
22/08/202310:15GLOBEAlvotech to Report Financial Results for the First Half of..
31/07/202305:00GLOBEAlvotech Completes $100 Million Convertible Bond Private..
24/07/202305:00GLOBETeva Pharmaceuticals and Alvotech Provide Update on..
03/07/202310:37DJNAlvotech Shares Rebound 20% After FDA Letter Selloff
28/06/202321:03DJNAlvotech Gets FDA Letter, Expects Delay in U.S. Approval of..
28/06/202320:00GLOBEAlvotech Provides Regulatory Update on Second Biologics..
12/06/202308:00BWAlvotech and Teva Secure U.S. License Date for AVT04, a..
12/06/202304:00GLOBEAlvotech and Teva Secure U.S. License Date for AVT04, a..
31/05/202306:20GLOBEAlvotech to Participate in Jefferies Healthcare Conference
24/05/202306:00GLOBEAlvotech and Advanz Pharma extend strategic partnership to..
19/05/202306:00GLOBEAlvotech Reports Financial Results for First three Months of..
17/05/202306:00GLOBEAlvotech to Participate in Morgan Stanley Annual..
15/05/202306:00GLOBEAlvotech Issues Annual Equality Report Covering 2022
10/05/202306:00GLOBEAlvotech enters into commercialization agreement with..
04/05/202306:00GLOBEAlvotech Initiates Confirmatory Patient Study for AVT05, a..
03/05/202310:00GLOBEAlvotech to Report First Quarter 2023 Financial Results and..

Seu Histórico Recente

NASDAQ
ALVO
Alvontech
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados